- Record: found
- Abstract: found
- Article: not found
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated for the treatment of rheumatoid arthritis.